Analyze Diet

Topic:Oral Administration

Oral administration in horses refers to the delivery of medications, supplements, or nutrients via the mouth. This method is commonly used in equine veterinary medicine for its practicality and ease of use. Oral formulations can include powders, pastes, or liquids, which are designed to be palatable and easily ingested by horses. The effectiveness of oral administration depends on factors such as the horse's digestive physiology, the formulation of the product, and the consistency with which it is administered. This page compiles peer-reviewed research studies and scholarly articles that explore the techniques, efficacy, and considerations of oral administration in equine care.
The detection of modafinil and its major metabolite in equine urine by liquid chromatography/mass spectrometry.
Rapid communications in mass spectrometry : RCM    April 19, 2005   Volume 19, Issue 10 1217-1220 doi: 10.1002/rcm.1910
McKinney AR, Suann CJ, Stenhouse AM.A method has been developed for the detection of modafinil and its major metabolite, modafinil acid, in equine urine by solid-phase extraction and positive ion electrospray ionisation liquid chromatography/mass spectrometry. The method has been applied to the analysis of equine urine samples obtained after the oral administration of modafinil. Modafinil acid was the major component in the urine, and was detected up to 4 days post-administration. Unchanged modafinil was present at substantially lower concentrations, and was detected for only 24 hours.
Metabolic responses to oral tryptophan supplementation before exercise in horses.
Journal of animal physiology and animal nutrition    March 25, 2005   Volume 89, Issue 3-6 140-145 doi: 10.1111/j.1439-0396.2005.00534.x
Vervuert I, Coenen M, Watermülder E.This study was conducted to evaluate the effects of oral tryptophan (Trp) supplementation on exercise capacity and metabolic responses in horses. Three horses had to perform an exercise test: a 15-min warm-up followed by a 60-min walk (1.7 m/s, W1), a 10-min trot (3.1 m/s, T1), a second 60-min walk (1.7 m/s, W2), a second 10-min trot (3.1 m/s, T2) and a final 30-min walk (1.7 m/s, W3) until the horses were unwilling to continue. The horses exercised on a treadmill at a 6% incline and with a constant draught load of 40 kg (0.44 kN). Two hours before exercise horses were given 50 g Trp (9.8-10.7...
[Equine exudative canker: an (auto-)immune disease?].
Tijdschrift voor diergeneeskunde    March 10, 2005   Volume 130, Issue 4 106-109 
Jongbloets AM, Sloet van Oldruitenborgh-Oosterbaan MM, Meeus PJ, Back W.Equine canker is a chronic, hyperplastic, exudative pododermatitis affecting one or more feet. Although many causes and treatments have been suggested, the cause of the disease is still unknown and most probably multifactorial. Local treatments include radical surgical debridement of the diseased hoof tissue and application of caustic substances, antibiotics, and pressure bandaging. Nevertheless, the number of recurrences is high (45%). This article presents a 3-year-old New Forest pony-cross mare in which all horny structures (frogs, coronets, spurs, chestnuts) of all feet were affected. Bact...
Disposition of orally administered cefpodoxime proxetil in foals and adult horses and minimum inhibitory concentration of the drug against common bacterial pathogens of horses.
American journal of veterinary research    February 5, 2005   Volume 66, Issue 1 30-35 doi: 10.2460/ajvr.2005.66.30
Carrillo NA, Giguère S, Gronwall RR, Brown MP, Merritt KA, O'Kelley JJ.To determine the disposition of orally administered cefpodoxime proxetil in foals and adult horses and measure the minimum inhibitory concentrations (MICs) of the drug against common bacterial pathogens of horses. Methods: 6 healthy adult horses and 6 healthy foals at 7 to 14 days of age and again at 3 to 4 months of age. Methods: A single dose of cefpodoxime proxetil oral suspension was administered (10 mg/kg) to each horse by use of a nasogastric tube. In 7- to 14-day-old foals, 5 additional doses were administered intragastrically at 12-hour intervals. The MIC of cefpodoxime for each of 173...
Effect of prolonged use of altrenogest on behaviour in mares.
Veterinary journal (London, England : 1997)    February 3, 2005   Volume 169, Issue 1 113-115 doi: 10.1016/j.tvjl.2004.04.020
Hodgson D, Howe S, Jeffcott L, Reid S, Mellor D, Higgins A.Oral administration of altrenogest for oestrus suppression in competition horses is believed to be widespread in some equestrian disciplines, and can be administered continuously for several months during a competition season. To examine whether altrenogest has any anabolic or other potential performance enhancing properties that may give a horse an unfair advantage, we examined the effect of oral altrenogest (0.044 mg/kg), given daily for a period of eight weeks, on social hierarchy, activity budget, body-mass and body condition score of 12 sedentary mares. We concluded that prolonged oral ad...
Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.
Arthritis and rheumatism    January 11, 2005   Volume 52, Issue 1 181-191 doi: 10.1002/art.20762
Laverty S, Sandy JD, Celeste C, Vachon P, Marier JF, Plaas AH.To examine the concentration of glucosamine in the synovial fluid and its pharmacokinetics in serum in a large animal model following dosing with glucosamine HCl at clinically relevant levels. Methods: Eight adult female horses were studied. After an overnight fast, glucosamine HCl (20 mg/kg of body weight) was administered by either nasogastric (NG) intubation or intravenous (IV) injection. Blood samples were collected before dosing and at 5, 15, 30, 60, 120, 180, 240, 360, 480, and 720 minutes after dosing. Synovial fluid samples were collected from the radiocarpal joints 48 hours before dos...
Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
Journal of veterinary pharmacology and therapeutics    December 17, 2004   Volume 27, Issue 6 479-490 doi: 10.1111/j.1365-2885.2004.00617.x
Lees P, Landoni MF, Giraudel J, Toutain PL.This review summarises selected aspects of the pharmacokinetics (PK) and pharmacodynamics (PD) of nonsteroidal anti-inflammatory drugs (NSAIDs). It is not intended to be comprehensive, in that it covers neither minor species nor several important aspects of NSAID PD. The limited objective of the review is to summarise those aspects of NSAID PK and PD, which are important to an understanding of PK-PD integration and PK-PD modelling (the subject of the next review in this issue). The general features of NSAID PK are: usually good bioavailability from oral, intramuscular and subcutaneous administ...
Pharmacokinetics of meloxicam in plasma and urine of horses.
American journal of veterinary research    November 30, 2004   Volume 65, Issue 11 1542-1547 doi: 10.2460/ajvr.2004.65.1542
Toutain PL, Reymond N, Laroute V, Garcia P, Popot MA, Bonnaire Y, Hirsch A, Narbe R.To determine pharmacokinetic parameters for meloxicam, a nonsteroidal anti-inflammatory drug, in horses. Methods: 8 healthy horses. Methods: In the first phase of the study, horses were administered meloxicam once in accordance with a 2 x 2 crossover design (IV or PO drug administration; horses fed or not fed). The second phase used a multiple-dose regimen (daily oral administration of meloxicam for 14 days), with meloxicam administered at the recommended dosage (0.6 mg/kg). Plasma and urine concentrations of meloxicam were measured by use of validated methods with a limit of quantification of...
Pharmacokinetics and pharmacodynamics of furosemide after oral administration to horses.
Journal of veterinary internal medicine    November 2, 2004   Volume 18, Issue 5 739-743 doi: 10.1892/0891-6640(2004)18<739:papofa>2.0.co;2
Johansson AM, Gardner SY, Levine JF, Papich MG, Lafevers DH, Goldman RB, Sheets MK, Atkins CE.Furosemide is the most common diuretic drug used in horses. Furosemide is routinely administered as IV or IM bolus doses 3-4 times a day. Administration PO is often suggested as an alternative, even though documentation of absorption and efficacy in horses is lacking. This study was carried out in a randomized, crossover design and compared 8-hour urine volume among control horses that received placebo, horses that received furosemide at 1 mg/kg PO, and horses that received furosemide at 1 mg/kg IV. Blood samples for analysis of plasma furosemide concentrations, PCV, and total solids were obta...
Effects of trimethoprim-sulfadiazine on tear production and the fluctuations of Schirmer tear test values in horses.
Veterinary ophthalmology    October 30, 2004   Volume 7, Issue 6 385-390 doi: 10.1111/j.1463-5224.2004.04037.x
Rothschild CM, Sellon DC, Bryan GM, Gay JM, Hines MT.The objectives of this study were to observe the effects of trimethoprim-sulfadiazine on equine tear production and to determine normal fluctuations in Schirmer tear test (STT) values in horses. A randomized, placebo-controlled, blinded clinical trial measuring STT values in 15 horses over an 8-week period was performed. The treatment group (eight horses) received 30 mg/kg trimethoprim-sulfadiazine orally once a day and the control group (seven horses) received placebo (flour) at the same time. All horses were housed outdoors throughout the study. Schirmer tear test values were measured at 0, ...
Biological availability of inhaled fluticasone propionate in horses.
The Veterinary record    October 21, 2004   Volume 155, Issue 12 361-364 doi: 10.1136/vr.155.12.361
Laan TT, Westermann CM, Dijkstra AV, van Nieuwstadt RA, Fink-Gremmels J.Healthy horses received aerosolised, intranasal or oral doses of 3 mg of fluticasone propionate evenly divided over morning and evening treatments for seven days. The bioavailability of the drug was determined in terms of the suppression of the endogenous cortisol concentrations in the horses during the period of treatment. The horses which received the aerosolised drug had significantly lower concentrations of endogenous cortisol on days 5 and 8 than the horses which received aerosolised placebo. The horses which received nasal and oral doses of fluticasone propionate showed no significant ch...
Pharmacokinetics, stability, and retrospective analysis of use of an oral gel formulation of the bovine injectable enrofloxacin in horses.
Veterinary therapeutics : research in applied veterinary medicine    October 7, 2004   Volume 5, Issue 2 155-167 
Epstein K, Cohen N, Boothe D, Nieuwoudt C, Chandler J.In many cases of equine infectious disease, long-term administration of antimicrobial drugs is required. Oral agents are preferred because of the relative ease of administration compared with other routes. Enrofloxacin has been shown to be effective against a variety of equine pathogens, but oral administration of this drug has proved difficult in horses. An oral gel formulation made from the injectable cattle product produces blood levels sufficient to resolve infections caused by a variety of common equine pathogens.
The detection of piroxicam, tenoxicam and their metabolites in equine urine by electrospray ionisation ion trap mass spectrometry.
Rapid communications in mass spectrometry : RCM    September 24, 2004   Volume 18, Issue 19 2338-2342 doi: 10.1002/rcm.1631
McKinney AR, Suann CJ, Stenhouse AM.An investigation has been conducted into the metabolism and urinary excretion of orally administered piroxicam and tenoxicam in the horse. The major component detected in urine after the administration of piroxicam was 5'-hydroxypiroxicam, which was detectable up to 24 h post-administration. Unchanged piroxicam was present only as a minor component. In contrast, unchanged tenoxicam was the major component observed after the administration of tenoxicam, being detectable for 72 h post-administration, while 5'-hydroxytenoxicam was a minor component. Phase II beta-glucuronide conjugation in each c...
Effect of omeprazole paste on intragastric pH in clinically normal neonatal foals.
American journal of veterinary research    September 1, 2004   Volume 65, Issue 8 1039-1041 doi: 10.2460/ajvr.2004.65.1039
Sanchez LC, Murray MJ, Merritt AM.To evaluate the efficacy of omeprazole paste, a commonly used antiulcer drug, on intragastric pH in clinically normal neonatal foals. Methods: 6 clinically normal foals between 5 and 14 days of age. Methods: Intragastric pH was recorded in each foal by use of a disposable antimony pH electrode with internal reference. Values for intragastric pH were recorded every 4 seconds by use of an ambulatory pH monitor. There were two 24-hour recordings of intragastric pH for each foal, with 24 hours between recordings. Foals were not administered any drugs during the first recording. Foals were administ...
Treatment of inflammatory airway disease in young standardbreds with interferon alpha.
The Canadian veterinary journal = La revue veterinaire canadienne    August 20, 2004   Volume 45, Issue 7 594-601 
Moore I, Horney B, Day K, Lofstedt J, Cribb AE.The effect of oral treatment with natural or recombinant human interferon alpha (HIA) on inflammatory airway disease in young standardbreds was assessed in a double-blind, randomized clinical trial. A total of 34 horses with nasal discharge, excess mucus in the trachea, and a persistent cough of at least 2 weeks' duration that interfered with training completed the trial. Horses were rested for 1 week and received oral treatment with either a saline placebo, recombinant human interferon alpha (rHIA; 90 U/horse/day), or natural human interferon alpha (nHIA: 50 U/horse/day) for 5 days. There was...
Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction.
Equine veterinary journal    July 16, 2004   Volume 36, Issue 5 426-430 doi: 10.2746/0425164044868413
Cornelisse CJ, Robinson NE, Berney CE, Kobe CA, Boruta DT, Derksen FJ.Although the efficacy of dexamethasone for the treatment of recurrent airway obstruction (RAO) has been documented, the speed of onset of effect and duration of action are unknown, as is the efficacy of orally administered dexamethasone with or without fasting. Objective: To document the time of onset of effect and duration of action of a dexamethasone solution i.v. or orally with and without fasting. Methods: Protocol 1 used 8 RAO-affected horses with airway obstruction in a crossover design experiment that compared the effect of i.v. saline and dexamethasone (0.1 mg/kg bwt) on pulmonary func...
Effect of L-carnitine administration on the seminal characteristics of oligoasthenospermic stallions.
Theriogenology    July 1, 2004   Volume 62, Issue 3-4 761-777 doi: 10.1016/j.theriogenology.2003.11.018
Stradaioli G, Sylla L, Zelli R, Chiodi P, Monaci M.The effect of orally administered l-carnitine on the quality of semen obtained from stallions with different semen qualities was investigated. Four stallions with proven fertility (high motility group, HM) and with normal seminal characteristics (>50% progressive motility and > 80 x 10(6) spermatozoa/ml), and four questionable breeders (low motility group, LM) with <50% of sperm progressive motility and < 80 x 10(6) spermatozoa/ml, received p.o. 20 g of l-carnitine for 60 days. Blood and semen samples were collected before treatment (T0) and after 30 (T1) and 60 days (T2). Semen ev...
Detection of enrofloxacin and its metabolite ciprofloxacin in equine hair.
Research in veterinary science    June 16, 2004   Volume 77, Issue 2 143-151 doi: 10.1016/j.rvsc.2004.03.004
Dunnett M, Richardson DW, Lees P.Hair analysis to detect drug administration has not been studied extensively in horses. This study aimed to (a) develop an analytical method for enrofloxacin and its metabolite ciprofloxacin in mane and tail hair, (b) relate measured values to doses, routes of administration, hair colour, and (c) demonstrate long-term detectability. Samples were extracted in trifluoroacetic acid at 70 degrees C. Extracts were cleaned-up by solid-phase extraction and analysed by high-performance liquid chromatography with UV-diode array detection. Analyte recoveries were > 87%. Horses were sampled after therape...
Effects of trimethoprim-sulfadiazine on thyroid function of horses.
Journal of veterinary internal medicine    June 11, 2004   Volume 18, Issue 3 370-373 doi: 10.1892/0891-6640(2004)18<370:eototf>2.0.co;2
Rothschild CM, Hines MT, Breuhaus B, Gay J, Sellon DC.Trimethoprim-sulfadiazine was administered to horses in a randomized, placebo controlled study to determine the effects of potentiated sulfonamides on thyroid function in normal horses. The treatment group included eight horses that received trimethoprim-sulfadiazine mixed with molasses orally at 30 mg/kg once daily for eight weeks. The control group included 8 horses that received an oral placebo (flour mixed with molasses) once daily for the same period. Thyroid function was evaluated prior to initiation of treatment and after 8 weeks of treatment. Serum concentrations of total and free trii...
Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.
Journal of veterinary pharmacology and therapeutics    June 11, 2004   Volume 27, Issue 3 183-186 doi: 10.1111/j.1365-2885.2004.00575.x
Pellegrini-Masini A, Poppenga RH, Sweeney RW.An injectable preparation of flunixin meglumine was administered orally and intravenously at a dose of 1.1 mg/kg to six healthy adult horses in a cross-over design. Flunixin meglumine was detected in plasma within 15 min of administration and peak plasma concentrations were observed 45-60 min after oral administration. Mean bioavailability of the oral drug was 71.9 +/- 26.0%, with an absorption half-life of 0.76 h. The apparent elimination half-life after oral administration was 2.4 h. The injectable preparation of flunixin meglumine is suitable for oral administration to horses.
Effects of enteral and intravenous fluid therapy, magnesium sulfate, and sodium sulfate on colonic contents and feces in horses.
American journal of veterinary research    May 15, 2004   Volume 65, Issue 5 695-704 doi: 10.2460/ajvr.2004.65.695
Lopes MA, White NA, Donaldson L, Crisman MV, Ward DL.To assess changes in systemic hydration, concentrations of electrolytes in plasma, hydration of colonic contents and feces, and gastrointestinal transit in horses treated with IV fluid therapy or enteral administration of magnesium sulfate (MgSO4), sodium sulfate (NaSO4), water, or a balanced electrolyte solution. Methods: 7 horses with fistulas in the right dorsal colon (RDC). Methods: In a crossover design, horses alternately received 1 of 6 treatments: no treatment (control); IV fluid therapy with lactated Ringer's solution; or enteral administration of MgSO4, Na2SO4, water, or a balanced e...
Field evaluation of moxidectin/praziquantel oral gel in horses.
Veterinary therapeutics : research in applied veterinary medicine    May 12, 2004   Volume 4, Issue 3 249-256 
Grubbs ST, Amodie D, Rulli D, Wulster-Radcliffe M, Reinemeyer C, Yazwinski T, Tucker C, Hutchens D, Smith L, Patterson D.The safety and efficacy of 2% moxidectin/12.5% praziquantel oral gel administered at a rate of 0.4 mg moxidectin and 2.5 mg praziquantel/kg was studied in client-owned horses under field use conditions. Four hundred horses (300 treated with moxidectin/praziquantel oral gel and 100 treated with vehicle) were enrolled, feces were collected, and eggs were counted. Investigators as well as horse owners were masked to treatment assignment. No adverse reactions to treatment were observed in any horses. Moxidectin/praziquantel gel reduced Anoplocephala spp by more than 99% and provided a significant ...
Field efficacy of ivermectin plus praziquantel oral paste against naturally acquired gastrointestinal nematodes and cestodes of horses in North America and Europe.
Veterinary therapeutics : research in applied veterinary medicine    May 12, 2004   Volume 4, Issue 3 220-227 
Rehbein S, Holste JE, Doucet MY, Fenger C, Paul AJ, Reinemeyer CR, Smith LL, Yoon S, Marley SE.The efficacy of an oral formulation of ivermectin plus praziquantel in the reduction of nematode and cestode egg counts in horses was assessed in 273 horses under field conditions at 15 sites in North America (n = 6) and Europe (n = 9). Horses were confirmed by fecal examination to have natural infections of strongyles (100%) and tapeworms (76%). Replicates of four horses were formed at each site, and in each replicate three animals received ivermectin (0.2 mg/kg body weight) plus praziquantel (1 mg/kg body weight) oral paste and one animal remained untreated or received vehicle paste. Fecal s...
Detection, quantification, metabolism, and behavioral effects of selegiline in horses.
Veterinary therapeutics : research in applied veterinary medicine    May 12, 2004   Volume 4, Issue 3 257-268 
Dirikolu L, Lehner AF, Karpiesiuk W, Hughes C, Woods WE, Boyles J, Harkins JD, Troppmann A, Tobin T.Selegiline ([R]-[-]N,alpha-dimethyl-N-2- propynylphenethylamine or l-deprenyl), an irreversible inhibitor of monoamine oxidase, is a classic antidyskinetic and antiparkinsonian agent widely used in human medicine both as monotherapy and as an adjunct to levodopa therapy. Selegiline is classified by the Association of Racing Commissioners International (ARCI) as a class 2 agent, and is considered to have high abuse potential in racing horses. A highly sensitive LC/MS/MS quantitative analytical method has been developed for selegiline and its potential metabolites amphetamine and methamphetamine...
Tissue distribution of clenbuterol in the horse.
Journal of veterinary pharmacology and therapeutics    April 21, 2004   Volume 27, Issue 2 91-98 doi: 10.1111/j.1365-2885.2004.00558.x
Soma LR, Uboh CE, Guan F, Luo Y, Teleis D, Runbo L, Birks EK, Tsang DS, Habecker P.Plasma and tissue concentrations of clenbuterol (CLB) were determined following oral (p.o.) administration of 1.6 microg/kg twice daily (b.i.d.) for 2 weeks. Horses were administered the last dose on morning of day 15, killed at 0.25, 24, 48, and 72 h post-administration. At 0.25 h, the highest tissue concentrations of CLB were found in the liver (16.21 ng/g), lung (6.48 ng/g), left ventricle (4.99 ng/g), kidney (3.35 ng/g), bronchi (2.56 ng/g), right ventricle (2.08 ng/g), and eye fluids (1.09 ng/g) all of which were higher than that of plasma (1.10 ng/mL). The elimination half-lives (t(1/2k)...
Pharmacokinetics and disposition of clenbuterol in the horse.
Journal of veterinary pharmacology and therapeutics    April 21, 2004   Volume 27, Issue 2 71-77 doi: 10.1111/j.1365-2885.2004.00553.x
Soma LR, Uboh CE, Guan F, Moate P, Luo Y, Teleis D, Li R, Birks EK, Rudy JA, Tsang DS.The pharmacokinetics of clenbuterol (CLB) following a single intravenous (i.v.) and oral (p.o.) administration twice daily for 7 days were investigated in thoroughbred horses. The plasma concentrations of CLB following i.v. administration declined mono-exponentially with a median elimination half-life (t(1/2k)) of 9.2 h, area under the time-concentration curve (AUC) of 12.4 ng.h/mL, and a zero-time concentration of 1.04 ng/mL. Volume of distribution (V(d)) was 1616.0 mL/kg and plasma clearance (Cl) was 120.0 mL/h/kg. The terminal portion of the plasma curve following multiple p.o. administrati...
The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse.
Biopharmaceutics & drug disposition    April 15, 2004   Volume 25, Issue 3 109-116 doi: 10.1002/bdd.392
Du J, White N, Eddington ND.The purpose of this study was to determine if glucosamine (GL) hydrochloride (FCHG49) and low molecular weight (LMW) chondroitin sulfate (CS) (TRH122) are absorbed after oral administration to horses. The bioavailability of LMWCS was evaluated by quantifying the total disaccharides found in the plasma following chondroitinase ABC digestion. Methods: Two separate studies were conducted. In study 1, ten adult horses received the following four treatments in a randomized crossover fashion: (1) i.v. LMWCS (3 g of 8 kDa), (2) p.o. LMWCS (3 g of 8 kDa), (3) i.v. LMWCS (3 g of 16.9 kDa) and (4) p.o. ...
Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses.
Journal of veterinary internal medicine    April 3, 2004   Volume 18, Issue 2 231-237 doi: 10.1892/0891-6640(2004)18<231:cotpap>2.0.co;2
Gardner SY, Atkins CE, Sams RA, Schwabenton AB, Papich MG.The pharmacokinetics of enalapril (0.5 mg/kg i.v.) and the pharmacodynamics of enalapril (0.5 mg/kg PO) in 5 mares were investigated. After single i.v. dosing, concentrations of enalapril and enalaprilat, its active metabolite, were measured. Two weeks later, enalapril was administered by nasogastric tube. Potassium, creatinine, blood urea nitrogen (BUN), enalapril, and enalaprilat concentrations and angiotensin converting enzyme (ACE) activity were measured in serum. In addition, heart rate, blood pressure, digital venous blood gases, and lactate were measured. Two weeks later, enalapril was ...
Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing.
Journal of veterinary pharmacology and therapeutics    March 5, 2004   Volume 27, Issue 1 57-60 doi: 10.1046/j.0140-7783.2003.00529.x
Gardner SY, Davis JL, Jones SL, LaFevers DH, Hoskins MS, McArver EM, Papich MG.No abstract available
Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis.
American journal of veterinary research    January 15, 2004   Volume 65, Issue 1 74-79 doi: 10.2460/ajvr.2004.65.74
McKenzie EC, Valberg SJ, Godden SM, Finno CJ, Murphy MJ.To determine the effect of oral administration of dantrolene sodium on serum creatine kinase (CK) activity after exercise in horses with recurrent exertional rhabdomyolysis (RER). Methods: 2 healthy horses and 5 Thoroughbreds with RER. Methods: 3 horses received 2 doses of dantrolene (4, 6, or 8 mg/kg, p.o., with and without withdrawal of food) 2 days apart; 90 minutes after dosing, plasma dantrolene concentration was measured spectrofluorometrically. On the basis of these results, 5 Thoroughbreds with RER from which food was withheld received dantrolene (4 mg/kg) or an inert treatment (water ...
1 13 14 15 16 17 26